Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Giulia Caratti"'
Autor:
Chiara Romualdi, Sergio Marchini, Maurizio D'Incalci, Chiara Ghimenti, Costantino Mangioni, Lorenzo Ceppi, Laura Mannarino, Stefano Cagnin, Giovanna Chiorino, Ilaria Craparotta, Dionyssios Katsaros, Patrizia Perego, Enrico Sartori, Franco E. Odicino, Eliana Bignotti, Antonella Ravaggi, Gabriele Sales, Enrica Calura, Luca Beltrame, Robert Fruscio, Maurizia Mello-Grand, Giulia Caratti, Lara Paracchini, Paolo Martini
Purpose: Stage I epithelial ovarian cancer (EOC) represents about 10% of all EOCs and is characterized by good prognosis with fewer than 20% of patients relapsing. As it occurs less frequently than advanced-stage EOC, its molecular features have not
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35a0cd5da6ee861322569a50d2abd97e
https://doi.org/10.1158/1078-0432.c.6525615.v1
https://doi.org/10.1158/1078-0432.c.6525615.v1
Autor:
Maurizio D'Incalci, Cristina Matteo, Benedetta Colmegna, M.V. Perlangeli, Domenica Lorusso, Luca Porcu, Francesco Raspagliesi, Delia Mezzanzanica, Robert Fruscio, M. Romano, Eugenio Erba, Mariella Ferrari, Massimo Zucchetti, Giulia Caratti, Marco Gobbi, Nicolò Panini
Publikováno v:
Biochemical Pharmacology. 144:52-62
Trabectedin and its analogue lurbinectedin are effective drugs used in the treatment of ovarian cancer. Since the presence of ascites is a frequent event in advanced ovarian cancer we asked the question whether ascites could modify the activity of th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8de0f07b117f85ebaf0b01fd73d125a6
https://doi.org/10.1016/j.bcp.2017.08.001
https://doi.org/10.1016/j.bcp.2017.08.001
Autor:
Luca Beltrame, Enrico Sartori, Franco Odicino, Chiara Romualdi, Eliana Bignotti, Stefano Cagnin, Dionyssios Katsaros, Lorenzo Ceppi, Maurizia Mello-Grand, Giulia Caratti, Paolo Martini, Enrica Calura, Ilaria Craparotta, Antonella Ravaggi, Maurizio D'Incalci, Sergio Marchini, Laura Mannarino, Lara Paracchini, Patrizia Perego, Robert Fruscio, Costantino Mangioni, Giovanna Chiorino, C Ghimenti, Gabriele Sales
Purpose: Stage I epithelial ovarian cancer (EOC) represents about 10% of all EOCs and is characterized by good prognosis with fewer than 20% of patients relapsing. As it occurs less frequently than advanced-stage EOC, its molecular features have not
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc979bcd52043f84735f096c03177297
http://hdl.handle.net/10281/151517
http://hdl.handle.net/10281/151517
Autor:
Giovanni Scambia, Maurizio D'Incalci, Luca Beltrame, Enrico Sartori, Massimo Negrini, Antonella Ravaggi, Chiara Romualdi, Angela Gambino, Manuela Ferracin, Franco Odicino, Eliana Bignotti, Lara Paracchini, Lorenzo Maragoni, Elisa Salviato, Laura Zanotti, Sergio Marchini, Enrica Calura, Paola Todeschini, Paolo Martini, Germana Tognon, Marco Petrillo, Daniela Gallo, Giulia Caratti
High-grade serous ovarian carcinoma (HGSOC) is the most lethal gynecologic neoplasm, with five-year survival rate below 30%. Early disease detection is of utmost importance to improve HGSOC cure rate. Sera from 168 HGSOC patients and 65 healthy contr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a6507336e325f771f67caf3308bcf4a
http://hdl.handle.net/11577/3229401
http://hdl.handle.net/11577/3229401